AMCR Amcor
Scaled packaging utility; modest upside only if Berry synergies lift margins toward 11% and debt falls.
The story
Amcor is the world's largest consumer packaging converter. Since the Berry Global merger it has roughly $23.5B of revenue across flexibles and rigid plastics. Its moat comes from scale, procurement leverage and sticky FMCG and healthcare customer relationships, and it is a mature, low-growth business. Value creation now depends on delivering Berry cost synergies and paying down roughly $13B of net debt, not on top-line expansion.
Growth stays at about 2.5% (volume plus pricing). The reported 17% five-year CAGR is acquisition-driven and not organic. I nudged the target margin from 10.5% to 11% (a 5% relative move) because the full-year Berry results show the GAAP margin recovering to 8.3% while integration costs and acquired-intangible amortization still depress it, and the roughly $650M synergy target supports pre-merger Amcor-level economics. Sales-to-capital stays at 1.5 because marginal organic reinvestment is far more efficient than the 0.91 headline figure, which is weighed down by merger goodwill.
Value drivers
| Revenue growth (Y1) | 2.5% |
| Terminal growth | 2.5% |
| Forecast horizon | 5y |
| Target operating margin | 11.0% |
| Years to target margin | 4 |
| Sales-to-capital | 1.50 |
| Beta | 1.05 |
| Failure probability | 2.0% |
| Cost of capital (WACC) | 9.3% |
| Terminal WACC | 9.2% |
Valuation bridge
| PV of explicit FCFF | 6.89B |
| PV of terminal value | 18.04B |
| Equity value | 11.78B |
| ÷ shares → per share | $25.50 |
Projected free cash flow to the firm
| Yr | Revenue | Growth | Margin | NOPAT | Reinvest | FCFF | PV |
|---|---|---|---|---|---|---|---|
| 1 | 24.09B | 2.5% | 9.0% | 1.86B | 391.77M | 1.47B | 1.35B |
| 2 | 24.70B | 2.5% | 9.7% | 2.05B | 401.56M | 1.65B | 1.38B |
| 3 | 25.31B | 2.5% | 10.3% | 2.25B | 411.60M | 1.83B | 1.41B |
| 4 | 25.95B | 2.5% | 11.0% | 2.45B | 421.89M | 2.03B | 1.42B |
| 5 | 26.59B | 2.5% | 11.0% | 2.51B | 432.44M | 2.08B | 1.33B |
Key risks
- Berry synergy shortfall or integration missteps leave margins stuck near 8%
- Weak consumer volumes and resin price volatility squeeze spreads
- High leverage (about 3.5x net debt/EBITDA) limits flexibility if rates stay elevated; plastics regulation and EPR fees add structural cost
Catalysts
- Visible synergy capture and EBIT margin expansion in FY27 results
- Deleveraging toward 3x, shifting enterprise value from debt to equity